Babighian S, Zanella M, Gattazzo I, Galan A, Gagliano C, DEsposito F
Adv Exp Med Biol. 2024; 1474():105-118.
PMID: 39259423
DOI: 10.1007/5584_2024_819.
Bansal M
Indian J Ophthalmol. 2024; 73(Suppl 1):S31-S36.
PMID: 39257094
PMC: 11834934.
DOI: 10.4103/IJO.IJO_3334_23.
Hampton C, Bharti K, Song M
Curr Opin Biomed Eng. 2024; 31.
PMID: 38962280
PMC: 11218818.
DOI: 10.1016/j.cobme.2024.100538.
Arif W, Narendran S, Kannan N, Ramasamy K, Veerappan M, Chidambaranathan G
Indian J Ophthalmol. 2024; 72(Suppl 4):S688-S695.
PMID: 38623706
PMC: 11338411.
DOI: 10.4103/IJO.IJO_2491_23.
Wu K, Tabari A, Mazerolle E, Tran S
Biomimetics (Basel). 2024; 9(3).
PMID: 38534830
PMC: 10968161.
DOI: 10.3390/biomimetics9030145.
Recent Progress in Retinal Pigment Epithelium Cell-Based Therapy for Retinal Disease.
Klymenko V, Gonzalez Martinez O, Zarbin M
Stem Cells Transl Med. 2024; 13(4):317-331.
PMID: 38394392
PMC: 11016854.
DOI: 10.1093/stcltm/szae004.
Recent Achievements in the Heterogeneity of Mammalian and Human Retinal Pigment Epithelium: In Search of a Stem Cell.
Rzhanova L, Markitantova Y, Aleksandrova M
Cells. 2024; 13(3.
PMID: 38334673
PMC: 10854871.
DOI: 10.3390/cells13030281.
Current state of stem cell research in non-human primates: an overview.
Wu J, Shi Y, Yang S, Tang Z, Li Z, Li Z
Med Rev (2021). 2024; 3(4):277-304.
PMID: 38235400
PMC: 10790211.
DOI: 10.1515/mr-2023-0035.
AMD and Stem Cell-Based Therapies.
Giacalone J, Parkinson D, Balikov D, Rao R
Int Ophthalmol Clin. 2023; 64(1):21-33.
PMID: 38146879
PMC: 10783850.
DOI: 10.1097/IIO.0000000000000510.
Biomaterials used for tissue engineering of barrier-forming cell monolayers in the eye.
Sasseville S, Karami S, Tchatchouang A, Charpentier P, Anney P, Gobert D
Front Bioeng Biotechnol. 2023; 11:1269385.
PMID: 37840667
PMC: 10569698.
DOI: 10.3389/fbioe.2023.1269385.
Advances in the engineering of the outer blood-retina barrier: From in-vitro modelling to cellular therapy.
Dujardin C, Habeler W, Monville C, Letourneur D, Simon-Yarza T
Bioact Mater. 2023; 31:151-177.
PMID: 37637086
PMC: 10448242.
DOI: 10.1016/j.bioactmat.2023.08.003.
Human and Pig Pluripotent Stem Cells: From Cellular Products to Organogenesis and Beyond.
Xuan Y, Petersen B, Liu P
Cells. 2023; 12(16).
PMID: 37626885
PMC: 10453631.
DOI: 10.3390/cells12162075.
Human Retinal Organoids in Therapeutic Discovery: A Review of Applications.
Cheng L, Kuehn M
Handb Exp Pharmacol. 2023; 281:157-187.
PMID: 37608005
PMC: 11631198.
DOI: 10.1007/164_2023_691.
Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery.
Gupta S, Lytvynchuk L, Ardan T, Studenovska H, Sharma R, Faura G
Stem Cells Transl Med. 2023; 12(8):536-552.
PMID: 37459045
PMC: 10427969.
DOI: 10.1093/stcltm/szad039.
Bifunctional MXene-Augmented Retinal Progenitor Cell Transplantation for Retinal Degeneration.
Tang Z, Liu Y, Xiang H, Dai X, Huang X, Ju Y
Adv Sci (Weinh). 2023; 10(25):e2302747.
PMID: 37379237
PMC: 10477897.
DOI: 10.1002/advs.202302747.
Single-cell transcriptomics reveals maturation of transplanted stem cell-derived retinal pigment epithelial cells toward native state.
Parikh B, Blakeley P, Regha K, Liu Z, Yang B, Bhargava M
Proc Natl Acad Sci U S A. 2023; 120(26):e2214842120.
PMID: 37339216
PMC: 10293804.
DOI: 10.1073/pnas.2214842120.
Advancing cell therapy for neurodegenerative diseases.
Temple S
Cell Stem Cell. 2023; 30(5):512-529.
PMID: 37084729
PMC: 10201979.
DOI: 10.1016/j.stem.2023.03.017.
Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report.
Fortress A, Miyagishima K, Reed A, Temple S, Clegg D, Tucker B
Stem Cell Res Ther. 2023; 14(1):53.
PMID: 36978104
PMC: 10053463.
DOI: 10.1186/s13287-023-03282-y.
Injectable PTHF-based thermogelling polyurethane implants for long-term intraocular application.
Zhang K, Liu Z, Lin Q, Boo Y, Ow V, Zhao X
Biomater Res. 2022; 26(1):70.
PMID: 36461130
PMC: 9716749.
DOI: 10.1186/s40824-022-00316-z.
Induced retinal pigment epithelial cells with anti-epithelial-to-mesenchymal transition ability delay retinal degeneration.
Tian H, Chen Z, Zhu X, Ou Q, Wang Z, Wu B
iScience. 2022; 25(10):105050.
PMID: 36185374
PMC: 9519511.
DOI: 10.1016/j.isci.2022.105050.